Totally agree. The stupid forecasts just waste everybody's time. He gets a few short term back slaps only to look completely incompetent when the reaI figures come out. There Is growth there. Stay of Twitter, stop talking about trains, stop giving fake forecasts and just announce stuff when it's actually real. It doesn't seem that hard. Most other companies manage to do it.
- Forums
- ASX - By Stock
- AVR
- Forecasting
Forecasting, page-3
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M |
Open | High | Low | Value | Volume |
$11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 156 | $11.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.00 | 6045 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 156 | 11.800 |
1 | 870 | 11.600 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
1 | 1000 | 11.200 |
Price($) | Vol. | No. |
---|---|---|
12.000 | 6045 | 3 |
12.400 | 198 | 1 |
12.500 | 429 | 1 |
12.850 | 1000 | 1 |
13.000 | 4000 | 2 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
AVR (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online